The efficacy of LED microneedle patch on hair growth in patient with androgenetic alopecia

/A0 个研究点目标入组 57 人开始时间: 2023年8月11日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1.Patients aged between 18 to 60 years of age.
•2.AGA Hamilton-Norwood Stages III to IV (including Type III vertex) were enrolled. Subjects must maintain the normal hair length, color and style during the study.
•3.Female pattern hair loss Ludwig type I-II

•1. Patients who are not interested or deny this study.
•2. Patient who is undertaking treatment for the disease before this study period: Treatment with topical medication within 6 months treatment with systemic medication (Finasteride within 12 months, Dutasteride within 18 months) Using shampoo for hair growth stimulation (non-medicated) treatment or taking hair supplements within 3 months. Any other treatment for hair growth within 1 month.
•3. Patient with FPHL as well as hypaerandrogenrtic stage ( according to patient history, physical examination, and investigation report)
•4. patient with other systemic disease ex. malnutrition, autoimmune disease
•5. Patient with lack of cooperation as well as psychological order.
•6. Patient with history of hair transplantation or restoration surgery.
•7. Patient who is unreliable or poor compliance

发起方